Evaluate the feasability and security of the autologous ASC for the femenine stress urinary incontinence
Evaluate safety of adipose derived stem cells to femenine urinary incontinence with local application
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
10
Intralesional application ASC
Hospital Universitario La Paz
Madrid, Madrid, Spain
RECRUITINGEvaluate the feasability and security of the autologous ASC for the feminine stress urinary incontinence
compress test (number dthe changes daily) urethrocystoscopy (morphology of urethra)
Time frame: 16 weeks
Quality of life assessment using the SF-12 Questionnaire
SF-12 questionnaire
Time frame: 1, 4, 16, 24 weeks
Adverse events
Data collection
Time frame: 1, 4, 16, 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.